NCT04455126View on ClinicalTrials.gov

Preservative-free Tafluprost Eye Drops in Newly Diagnosed Patients With Glaucoma

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

December 30, 2018

Study Completion Date

June 1, 2020

Conditions
Glaucoma
Interventions
DRUG

Preservative-free tafluprost eye drops

This was an open-label, non-randomized clinical study that aimed to assess the ocular signs and symptoms in 60 eyes of 30 newly diagnosed Egyptian glaucoma patients receiving preservative-free tafluprost eye drops

Trial Locations (1)

Unknown

Alexandria Faculty of Medicine, Alexandria

All Listed Sponsors
lead

Alexandria University

OTHER

NCT04455126 - Preservative-free Tafluprost Eye Drops in Newly Diagnosed Patients With Glaucoma | Biotech Hunter | Biotech Hunter